These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 24898552

  • 21. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry.
    Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, Böhm M.
    Eur Heart J; 2017 Jan 07; 38(2):93-100. PubMed ID: 28158510
    [Abstract] [Full Text] [Related]

  • 22. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
    Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Dimitriadis K, Choi JW, East C, D'Souza R, Sharp ASP, Ewen S, Walton A, Hopper I, Brar S, McKenna P, Fahy M, Böhm M.
    Lancet; 2022 Apr 09; 399(10333):1401-1410. PubMed ID: 35390320
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG, Maia GL, de Queiroz Carreira MA, Kiuchi T, Chen S, Andrea BR, Graciano ML, Lugon JR.
    Eur Heart J; 2013 Jul 09; 34(28):2114-21. PubMed ID: 23786861
    [Abstract] [Full Text] [Related]

  • 25. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 26. Catheter-based renal denervation for treatment of resistant hypertension.
    Vase H, Mathiassen ON, Kaltoft A, Pedersen EB, Christensen KL, Buus NH, Lederballe O, Lassen JF, Bøtker HE, Thuesen L.
    Dan Med J; 2012 Jun 10; 59(6):A4439. PubMed ID: 22677237
    [Abstract] [Full Text] [Related]

  • 27. Resistant Hypertension and Renal Nerve Denervation.
    Denker MG, Cohen DL.
    Methodist Debakey Cardiovasc J; 2015 Jun 10; 11(4):240-4. PubMed ID: 27057294
    [Abstract] [Full Text] [Related]

  • 28. Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.
    Vogel B, Kirchberger M, Zeier M, Stoll F, Meder B, Saure D, Andrassy M, Mueller OJ, Hardt S, Schwenger V, Strothmeyer A, Katus HA, Blessing E.
    Clin Res Cardiol; 2014 Feb 10; 103(2):117-24. PubMed ID: 24126436
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial.
    Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Véhier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G, Renal Denervation for Hypertension (DENERHTN) investigators.
    Lancet; 2015 May 16; 385(9981):1957-65. PubMed ID: 25631070
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial.
    Kandzari DE, Bhatt DL, Brar S, Devireddy CM, Esler M, Fahy M, Flack JM, Katzen BT, Lea J, Lee DP, Leon MB, Ma A, Massaro J, Mauri L, Oparil S, O'Neill WW, Patel MR, Rocha-Singh K, Sobotka PA, Svetkey L, Townsend RR, Bakris GL.
    Eur Heart J; 2015 Jan 21; 36(4):219-27. PubMed ID: 25400162
    [Abstract] [Full Text] [Related]

  • 33. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
    Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C, Brar S, Cohen SA, Fahy M, Pilcher G, Kario K, SPYRAL HTN-ON MED Trial Investigators.
    Lancet; 2018 Jun 09; 391(10137):2346-2355. PubMed ID: 29803589
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.
    Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, Polyakov K, Ptaszynski P, Keweloh B, Yao CJ, Pokushalov EA, Romanov AB.
    JAMA; 2020 Jan 21; 323(3):248-255. PubMed ID: 31961420
    [Abstract] [Full Text] [Related]

  • 36. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S, Meyer MR, Cremers B, Laufs U, Helfer AG, Linz D, Kindermann I, Ukena C, Burnier M, Wagenpfeil S, Maurer HH, Böhm M, Mahfoud F.
    Clin Res Cardiol; 2015 Dec 21; 104(12):1097-105. PubMed ID: 26306594
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis.
    Sobreira LER, Bezerra FB, Sano VKT, de Oliveira Macena Lôbo A, Cardoso JHCO, Kelly FA, de Moraes FCA, Consolim-Colombo FM.
    High Blood Press Cardiovasc Prev; 2024 Jul 21; 31(4):329-340. PubMed ID: 38890242
    [Abstract] [Full Text] [Related]

  • 38. Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?
    Armaganijan L, Staico R, Moraes A, Abizaid A, Moreira D, Amodeo C, Sousa M, Borelli F, Armaganijan D, Sousa JE, Sousa A.
    Arq Bras Cardiol; 2014 Apr 21; 102(4):355-63. PubMed ID: 24652055
    [Abstract] [Full Text] [Related]

  • 39. Symplicity multi-electrode radiofrequency renal denervation system feasibility study.
    Whitbourn R, Harding SA, Walton A.
    EuroIntervention; 2015 May 21; 11(1):104-9. PubMed ID: 25982652
    [Abstract] [Full Text] [Related]

  • 40. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL, SYMPLICITY HTN-3 Investigators.
    J Am Coll Cardiol; 2014 Sep 16; 64(11):1071-8. PubMed ID: 24858423
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.